NCT07322783 2026-01-07Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET AmplificationQingdao Central HospitalPhase 2 Recruiting60 enrolled
NCT03382795 2021-07-15Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive PatientsKorea University Guro HospitalPhase 2 Unknown63 enrolled